Saturday, March 17, 2012 10:20:57 PM
I think you guys are reading the filing wrong...
no one bought anything...
4 people RECIEVED stock options
(the RIGHT TO BUY AT 83¢, good until 2/16/2022)
here is a note from one of the Form 4's:
"On February 16, 2012, the Company granted an option to purchase 10,000 shares of common stock of the Company (the "Option") in respect of the service by Mr. Mieyal as a member of the Board of Directors of the Company. The Option was granted under the Company's 2004 Stock Incentive Plan. At the request of Mr. Mieyal, the Option was granted to Wexford Capital LP. The Option vested immediately with respect to 3,334 shares on February 16, 2012. The remainder of the Option vests in an installment of 3,333 shares on each of the first and second anniversary of the grant date."
see it says on the form "Non-qualified stock option (right to buy)"
look back and I'm sure you'll see they gift themselves with these options every year :)
no one bought anything...
4 people RECIEVED stock options
(the RIGHT TO BUY AT 83¢, good until 2/16/2022)
here is a note from one of the Form 4's:
"On February 16, 2012, the Company granted an option to purchase 10,000 shares of common stock of the Company (the "Option") in respect of the service by Mr. Mieyal as a member of the Board of Directors of the Company. The Option was granted under the Company's 2004 Stock Incentive Plan. At the request of Mr. Mieyal, the Option was granted to Wexford Capital LP. The Option vested immediately with respect to 3,334 shares on February 16, 2012. The remainder of the Option vests in an installment of 3,333 shares on each of the first and second anniversary of the grant date."
see it says on the form "Non-qualified stock option (right to buy)"
look back and I'm sure you'll see they gift themselves with these options every year :)
If ignorance is bliss, why aren't more people happy?
Recent NEPH News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:36:40 PM
- Nephros Announces Financial Results for Quarter Ended March 31, 2026 • GlobeNewswire Inc. • 05/07/2026 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:00:41 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/30/2026 08:05:34 PM
- Nephros Schedules First Quarter 2026 Financial Results Conference Call • GlobeNewswire Inc. • 04/30/2026 08:00:00 PM
- Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership • GlobeNewswire Inc. • 04/16/2026 01:57:04 PM
- Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise • GlobeNewswire Inc. • 04/01/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 08:00:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 08:54:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 08:53:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 08:17:19 PM
- Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results • GlobeNewswire Inc. • 03/12/2026 08:10:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 08:01:16 PM
- Nephros Schedules Fourth Quarter 2025 Financial Results Conference Call • GlobeNewswire Inc. • 03/05/2026 12:04:28 PM
- Nephros Expands into Puerto Rico to Deliver Differentiated Water Filtration Solutions Across Medical and Commercial Sectors • GlobeNewswire Inc. • 02/13/2026 01:16:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:15:32 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/14/2025 11:15:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2025 10:00:38 PM
- Nephros Announces Strong Third Quarter Financial Results; Achieving Highest Level of Programmatic Sales in Company History • GlobeNewswire Inc. • 11/06/2025 09:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 09:01:11 PM
- ¬Nephros Schedules Third Quarter 2025 Financial Results Conference Call • GlobeNewswire Inc. • 10/30/2025 08:00:00 PM
- Nephros Launches New PFAS Filter for Point-of-Use Protection of Potable Water • GlobeNewswire Inc. • 10/08/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2025 08:09:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2025 08:15:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2025 08:39:24 PM
